This article reports the investigation by 1H nuclear magnetic resonance (1H NMR) spectroscopy of biological fluids in a case of intentional poisoning with tetrahydrofuran (THF). Occupational exposures to this solvent are well documented, but acute poisoning cases are extremely rare, and the one presented here is the second known case of this kind. Urine and serum samples were collected. Without any pretreatment, the presence of THF was confirmed by characteristic resonances at 1.90 and 3.76 ppm; high lactate levels were also observed. The presence of 7-hydroxyhutyric acid (GHB) was noted. Quantitative analysis was performed by relative integration of peak areas. THF concentrations were 813 and 850 mg/L (11.3 and 11.8 retool/L), and GHB concentrations 239 and 2977 mg/L (2.3 and 28.6 retool/L) in serum and urine, respectively. A gas chromatographicmass spectrometric method confirmed 1H NMR observations. The origin of GHB detected in serum and urine is also discussed.
Introduction
Tetrahydrofuran (THF) is one of the cyclic ethers (CAS n~ with the molecular formula C4H80 and molecular weight of 72.11. This colorless compound is volatile (boiling point: 65-67~ with a liquid density of 0.889. It is miscible with water up to 300 g/L, and, because of its polarity, it is widely used as a solvent. THF can dissolve many types of plastics, such as polyvinyl chloride, polyurethanes, epoxy, and cellulosic resins, and a wide range of organic compounds. It is also used as a component of glues, paints, varnishes, and inks; it is a dispersing and stain-removing agent in textile processing and is also employed in the production of audio and video tapes (1) .
THF is readily absorbed through the alveolar membrane, the gastrointestinal tract, and the skin. It can be detected in blood, urine, and exhaled breath from exposed subjects (2) , but little information is available concerning its toxicokinetics (3) .
Human toxicity is essentially concerned and documented with occupational exposures (2,4). Ong et al. (2) presented the biological monitoring of 58 workers in a videotape manufacturing plant. After exposure to a concentration of 200 mL/m 3 (590 mg/m3), the extrapolated concentration of THF was 2.38 mg/L (33 IJmol/L) in blood and 8.07 mg/L (111.9 tJmol/L) in urine. Moreover, these authors suggested that THF concentration in urine could be a useful biological indicator of occupational exposure to THF. Symptoms following exposure may include nausea, headache, blurred vision, dizziness, tiredness, tinnitus, chest pain, and coughing. THF is an upper respiratory tract irritant, and irritation of skin and mucous membranes may be observed.
Toxicity data relative to THF is scarce. In a review article, Moody (3) presented results on experimental animals. Emerging from these, THF is considered as a weak toxin for humans and may induce hepatotoxicity only at high doses. The two major signs of poisoning are narcosis, linked to the solvent effect, and hepatocellular dysfunction. Acute poisoning cases are extremely rare. Only one published reference is available (5).
All published analytical techniques for THF determination involve gas chromatography (GC), often coupled with mass spectrometry (MS). The headspace method can be used for this volatile compound, but because of its high water solubility, the salting-out process must be applied (6) .
The aim of the present study was to point out the usefulness of 1H NMR spectroscopy in the investigation of urine and serum samples collected in a case of acute THF poisoning. This technique has already been applied to overdose cases involving salicylates (7), chloroquine (8) , and paraquat (9) in our laboratory. Structures of THF and GHB were confirmed by a GC-MS technique run on the same biological fluids (10).
Case History
A 55 year-old woman, who intentionally ingested organic solvent as well as psychoactive medication, was admitted to the Emergency Department of a general hospital. Her husband was the owner of a dry cleaning shop. On admission, she was in deep, hypotonous, and unreactive coma, with bilateral mydriasis.
She was immediately intubated and ventilated. Radiography revealed alveolar opacities suggesting an inhalation pneumopathy. Examination of the gastrointestinal tract revealed an ulcerated esophagitis without necrosis and purpuric gastritis.
Laboratory findings were as follows: blood pH = 7.33; Pco2 = 30 mm Hg; urea = 540 mg/L; creatinine --13 mg/L. The hepatic parameters were in the normal ranges. Toxicological screening performed by a high-performance liquid chromatography (HPLC) method revealed the presence of zolpidem (Stilnox | and fluoxetine (Prozac| No therapeutic treatment was found for this patient. Evolution included different progressive improvements: partial awakening after two days and execution of simple orders on day four. She had a tendency to be greatly excited and sometimes hallucinated. Esophagitis was clearly diminished on the fifth day. She was discharged from hospital after eight days without any sequelae.
Sample preparation
A 500-1aL sample (urine, serum, or standard solution) was introduced into a 5-mm diameter NMR tube. A sealed capillary tube containing a titrated solution of TSP-d4 in deuterium oxide was coaxially inserted into the NMR tube. TSP-d4 solution was used as reference for chemical shift (6 ] H = 0.00 ppm) and quantitation by relative surface integration. A presaturation sequence was used to suppress the intense water signal. Depending on the sample concentration, 128 to 512 transients were collected into a 16 K datapoint computer, with a spectral width of 3200 Hz and a 30 ~ pulse. Prior to Fourier transform, an exponential apodization function, corresponding to a 0.3 Hz broadening of the line, was applied. Data processing was carried out using the 1D WIN NMR program from Bruker. Calibration data was obtained from spiked control urines in the range 1-20 mmol/L for THF and 1-30 mmol/L for GHB.
In order to confirm the structure of THF, 1 mL of urine or serum samples was extracted with one volume of dichloromethane and 2 ~L from the organic layer was directly injected into the GC-MS apparatus. For GHB analyses, the general procedure for organic acid analysis was used (10): 5 mL urine was acidified and extracted twice with ethyl acetate. Organic layers were mixed and evaporated. They were then trimethylsilylated by BSTFA at 50~ for 20 min before injection into the GC-MS apparatus.
Experimental

Reagents
For 1H NMR spectroscopy, internal standard 3-(trimethylsilyl)-2,2,3,3-tetradeuteropropionic acid (TSP-d4) was purchased from Eurisotop (Saint Aubin, France). Other standard compounds were obtained from Sigma Aldrich (Saint Quentin Fallavier, France): tetrahydrofuran, y-hydroxy butyric acid (GHB), and bis-trimethylsilyl trifluoroacetamide (BSTFA), which was used as the silylation agent.
Sample collection
In the emergency toxicological context of this study, no specimens were specifically collected, and procedures were therefore in accordance with the revised Helsinki declaration of 1983.
Two biological samples were obtained: a urine and a blood sample collected in a glass container and a glass tube, respectively, on hospital admission. The blood sample was centrifuged. The urine and serum were then divided into two aliquots, immediately frozen, and stored at -20~ until analysis.
NMR and GC-MS analyses
1H NMR spectra were recorded on a Bruker DPX 300 MHz spectrometer (Bruker S.A., Wissembourg, France) at ambient probe temperature.
GC-MS analyses were performed on a Hewlett-Packard 5890 GC (Hewlett-Packard, Les Ulis, France) equipped with an SGE BPX5 (25 m x 0.25 ram) capillary column. GC was interfaced with an HP 5989 A quadrupole MS, and spectra were recorded in electron impact mode at 70 eV.
Results and Discussion
As THF poisoning was highly suspected (it is one of the products used in dry cleaning shops), 1H NMR spectrum of the standard was recorded in water ( Figure 1A ): THF was characterized by a multiplet at 1.90 ppm related to the two [~-methylene groups, and a multiplet at 3.76 ppm corresponding to the two D-methylene groups. From the 1H NMR spectrum of urine (Figure 2 ), several observations could be established. First, a characteristic signal at 1.90 ppm could be attributed to the two [3-methylene groups of THF ( Figure 2A) ; however, signals from the s-methylene groups (6 = 3.76 ppm) could not be detected because they were hidden by the wide signals of glucose ( Figure 2B) . Second, the usual resonances of normal urine samples were observed (Figure 2) : creatinine, alanine, citric and lactic acids, and in the aromatic part of the spectrum (Figure 2C ), hippurate and histidine. Apart from high lactaciduria at 2.28 g/L (6512 retool/tool creatinine), these compounds were within normal ranges (11, 12) . Third, unusual peaks that do not appear in normal urine samples could be seen on the spectrum ( Figure  2 ): a quintet at 1.77 ppm and two triplets at 2.22 and 3.58 ppm. These three groups of peaks of quite high and similar intensities were found to be due to the three methylene groups of GHB (13) . When a spectrum of standard GHB solution is recorded in the same experimental conditions as for the urine sample, three types of resonances are detected ( Figure 1B ): a quintet at 1.77 ppm corresponding to [3-CH2 and two triplets at 2.22 and 3.58 ppm corresponding to ~-and 7-CH2, respectively. In the patient's urine (Figures 2A and 2B) , the three signals of methylene groups corresponded exactly to those of standard GHB. For spiked control urine samples, a significant linear relationship was observed with a correlation coefficient r = 0.9998 (P = 1.0 x 10 -~) for THF. For GHB, r was 0.9999 (P = 9.2 x 10-s). All quantitation processes were run on [3-CH2 for THF and GHB, as interfering signals are not frequent in this part of the spectrum. Within-run and between-run precisions were also determined for both compounds, and the mean corresponding variation coefficients were 2.2 and 3.5% for THF and GHB, respectively. The quantitation limit was found to be 0.1 mmol/L for THF and 0.4 mmol/L for GHB. GC-MS analyses of dichloromethane extract of urine confirmed the presence of THF, as identified by its characteristic ions at m/z 72, 71, 42, 29, and 27. GC-MS analyses of urine organic acids confirmed the identity of trimethylsilylated GHB, characterized by rn/z 233, 204, 147, and 117, besides other normal endogenous compounds.
Similar findings were observed on the 1H NMR spectrum of the patient's serum (Figure 3 ): THF was identified by the multiplet at 1.90 ppm; the other one at 3.76 ppm, hidden by glucose signals, could be detected by 2D correlation experiments (data not shown). GHB was also detected by its resonances at 1.77 and 2.22 ppm, the 7-CH2 signal being also partially hidden. Signals of lactic acid were also present. Quantitative results for THF, GHB, and lactic acid are reported in Table I ; serum lactate was high (342 mg/L) and in accordance with the lactate level determined a few hours after admission (400 rag/L).
Hypothetical conversion of THF to GHB could account for the high lactate concentration found in the blood. This is an oxidation process and could involve reduction of NAD to NADH2. Such a process is already known to explain lactacidemia in other types of poisonings, such as ethanol and methanol intoxications.
On a molecular basis, concentrations of THF were in the same order of magnitude in serum and urine and were much higher than those reported in chronic poisoning (2), whereas GHB concentration was much higher in urine than in serum. This was already noted by Baselt and Cravey (14) in a case of GHB poisoning in which urine concentration was 10 times that of serum. In our case, urinary concentration is the highest ever recorded (2977 rag/L), much higher than in the case presented by Stephens and Baselt (15) , concerning a man who was asleep at the wheel under the influence of GHB. His urinary concentration was 1976 mg/L. In our patient, serum GHB was also high (239 mg/L), nearly reaching the highest value ever reported: 312 mg/L (16). Apart from poisoning cases with GHB, only one lethal case of poisoning with THF has been published (5), but the presence of GHB was not investigated.
As concentrations of THF and GHB were high in our patient and the origin of GHB quite puzzling, there may be a metabolic link between these two compounds. Two facts can be considered to support this hypothesis. First, the molecular ratio of GHB to THF was 0.20 in serum and 2.44 in urine. This could be consistent with the fact that the formation of GHB from THF may be a metabolic process. Moreover, this metabolic reaction requires an oxidative mechanism leading to the formation of an acidic compound, in agreement with general biotransformation reactions. This could explain that GHB concentration was much higher in urine than in serum. The second fact concerns ftorafur or 1-(tetrahydro-2-furanyl)-5-fluorouracyl. This anticancer agent presents a similar structure because it includes a tetrahydrofuran ring. E! Sayed and Sadee (17) reported that GHB is a major metabolite of this compound. According to these authors, microsomal oxidation of the tetrahydrofuran ring of ftorafur could lead to an ~-hydroxy derivative. The latter is expected to be chemically unstable and may lead to the formation of GHB. Such a link has been published by Bernhardt and Diekmann (18) for one bacterium: Rhodococcus ruber. It can hydroxylate THF on the 2-carbon, resulting in 2-hydroxy THF, which either isomerizes to 4-hydroxybutyraidehyde or can be oxidized to ybutyrolactone; both derivatives can then lead to GHB. In the pathway of tetrahydrofuran metabolism published by Bernhardt and Diekmann (18) , intermediate y-butyrolactone (GBL) was presented, leading to GHB by ring opening, and it has been established that ingested GBL can be converted into GHB in the human body (16) (Figure 4) . GBL poisonings are not as uncommon because GBL can be added to tonic or energygiving drinks; they may contain about 5.4 g of GBL per liter and some patients have drunk approximately 1 L of such drinks. Recently, the Centers for Disease Control and Prevention in Minnesota, New Mexico, and Texas (19) reported 41 cases involving GBL ingestion.
In order to characterize this compound, 1H NMR spectra of standard solutions were recorded. Three characteristic resonances could be observed: 2.25 ppm as a quintuplet assigned to the methylene group on C3; 2.55 ppm (triplet) due to the CH2 on C2 and 4.41 ppm (triplet) arising from the CH2 on C4. None of these signals could be detected in urine or serum spectra. It is thus possible that in this case of poisoning, THF was mainly metabolized to GHB, as the concentrations of possible intermediate compounds were below the detection limit.
Conclusions
This poisoning case is very exceptional; only one case of poisoning by ingestion was described in Japan in 1984 (5) . In the present case, THF, the ingested xenobiotic, was found in serum and urine by 1H NMR analysis. Moreover, the presence of y-hydroxy butyric acid (GHB) was also detected by the same analysis, whereas it was not expected at all. A metabolic link between the two compounds may exist. Several arguments concur with this hypothesis: the structural analogy, the molecular concentration ratio of the two compounds in serum and urine, which could indicate that GHB could have been produced from THF, as well as previous metabolic considerations.
However, no metabolic intermediate between THF and GHB could be detected. If a metabolic link could be proven, THF should be considered as a precursor of GHB, like ~,-butyrolactone.
1H NMR analysis of biological fluids may constitute a step forward in the diagnosis of some acute poisonings (20, 21). The present study points out two major benefits of NMR: any chemical species of the xenobiotic compounds concerned can be detected and, without limitation to a particular class of biological markers, NMR spectroscopy may reveal metabolic disturbances characteristic of poisoning. In the clinical case presented, lactate levels were directly determined during the same analytical process as THF and GHB quantitation. The relatively prompt and accurate qualitative and quantitative determinations of xenobiotics, their possible metabolites, and endogenous compounds are important to confirm or to help establish the diagnosis of THF poisoning so that the appropriate therapy can be performed.
